For patients classified as stage A hypertension, which of the following is a recommended therapy?

In patients classified as stage A hypertension, the recommended therapy involves antihypertensive therapy with tailored medical treatment. This stage indicates that individuals are at risk for developing hypertension but may not yet display significant symptoms or complications related to heart failure. The goal of treatment at this stage is to prevent the progression of hypertension and its associated risks.

Tailored medical treatment allows for the selection of specific antihypertensive medications that best suit the individual’s health status, comorbidities, and response to treatment. By addressing hypertension early with appropriate and personalized pharmacological interventions, clinicians aim to reduce the likelihood of long-term cardiovascular complications.

The other options do not fit the standard treatment guidelines for stage A hypertension. For instance, the use of digoxin is generally not appropriate as a first-line treatment for hypertension; it is utilized more in cases of heart failure or atrial fibrillation. Daily diuretic use is typically reserved for cases where fluid overload is evident, and immediate surgery for blood pressure control is not considered a standard practice for managing hypertension. Hence, pursuing a tailored approach involving antihypertensive therapy aligns with the standard of care for individuals in this classification.